To detect if nitric oxide (NO) is produced in rat forebrain ischemia, we applied an electron paramag netic resonance (EPR) NO-trapping technique. We also performed a detailed characterization of the technique. Diethyldithiocarbamate (DETC) and Fe-citrate were used as NO-trapping reagents. Under controlled ventilation, forebrain ischemia was produced by occlusion of both carotid arteries combined with hemorrhagic hypotension at 50 mm Hg for 15 min. DETC and Fe were administered 30 min prior to the onset of ischemia. During ischemia, the cerebral cortex was removed, and EPR samples were prepared. At liquid nitrogen temperatures, the NO-Fe DETC signal (a triplet signal centered at g = 2.039 with the hyperfine coupling constant aN of 13 G) was detected Abbreviations used: CCA, common carotid artery; DEA/NO, 1,I-diethyl-2-hydroxy-2-nitrosohydrazine; DETC, diethyldithio carbamate; EPR, electron paramagnetic resonance; Hb, hemo globin; L-NAME, N-nitro-L-arginine methyl ester; NMDA, N-methyl-o-aspartate; NOS, nitric oxide synthase.
Nitric oxide (NO) is a highly reactive regulatory molecule with a wide range of distribution through out the body, including the brain. Based upon its physiological role, the major sources of NO produc tion in the brain are thought to be endothelial cells and neurons (Palmer et al., 1988; Moncada et al., 1991; Bredt and Snyder, 1992) . NO or a related compound released from endothelial cells serves as an endothelium-derived relaxing factor that main tains and regulates vascular tone (Moncada et al., 1991; Vanin, 1991; Prado et al., 1992; Wang et al., overlapping Cu-DETC signals. By perfusing various con centrations of an NO-generating agent, 1, I-diethyl-2-hy droxy-2-nitrosohydrazine, into the rat brains, the amount of the "trapped NO" was calibrated. The size of the NO Fe-DETC signal was well correlated with the NO con centrations in the perfusate (correlation coefficient r = 0.998, P < 0.01). Based on this calibration curve, it was found that the amount of trapped NO during forebrain ischemia increased to seven times that of the control (control n = 5, forebrain ischemia n = 4, P < 0.005). Key Words: Brain ischemia-Diethyldithiocarbamate-l, 1-Di ethyl-2-hydroxy-2-nitrosohydrazine-Electron paramag netic resonance-Nitric oxide-Nitric oxide trapping. 1992; Buchanan and Phillis, 1993; Pelligrino et al. , 1993) . The neuronal production of NO is evidenced by the fact that a constitutive NO synthase (NOS) exists in neurons throughout the brain Vincent and Kimura, 1992; Nozaki et al., 1993) . NO acts as an intraneuronal and interneu ronal messenger by activating soluble guanylate cy clase and by blocking the N-methyl-o-aspartate (NMDA) receptor (Knowles et al., 1989; Garth waite, 1991; Bredt and Snyder, 1992; Lei et al., 1992; Manzoni et al., 1992) . NO is a free radical, and its short half-life «30 s) has rendered direct measurement difficult. To demonstrate the produc tion of NO indirectly, the levels of nitrite sjnitrates, stable metabolites of NO, and cyclic GMP have been measured. Alternatively, NOS inhibitors such as L-arginine analogues have been extensively used to prove the involvement of NO in in vivo reac tions. To understand NO-related pathology, it is es sential to have an exact profile of NO generation, for example, the time course and amount of NO production. Thus, a direct method that allows one to quantitate the amount of NO production is desir able.
The instability of NO can be overcome by using a NO-trapping technique, in which a more stable complex is formed and subsequently detected by electron paramagnetic resonance (EPR). Using the property that NO reacts with iron-sulfur com plexes, Vanin's group recently developed an NO trapping method using a diethyldithiocarbamate (DETC)-iron (Fe) complex (Kubrina et aI. , 1992; Voevodskaya and Vanin, 1992) . The NO-Fe-DETC complex forms a characteristic EPR signal with a triplet hyperfine structure centered around at g = 2.039. By applying this method, we have previously found that bilateral carotid artery occlusion poten tiates NO production in the rat brain (Sato et aI., 1993; Tominaga et aI., 1993) . Recently, the produc tion of NO in the ischemic brain was also studied using an NO-sensitive electrode (Malinski et aI., 1993) .
The EPR study of NO-metal complexes has sev eral decades of history (Henry et aI. , 1991) . How ever, NO trapping in the ischemic brain is a novel approach and therefore requires methodological characterization. The present study was undertaken to characterize the details of the NO-trapping method in the brain and further to evaluate the amount of NO production under severe ischemic conditions. To quantitate the amount of NO pro duced in the brain, we performed a transcardiac perfusion utilizing an NO-generating compound, 1, I-diethyl-2-hydroxy-2-nitrosohydrazine (DEAl NO) (Maragos et aI., 1991) , and prepared EPR spec imens. Using this calibration method, we estimated the concentration of trapped NO in forebrain isch emia. Detailed characteristics of this NO-trapping technique are described, and the relationship be tween this and the electrode method is discussed.
MATERIALS AND METHODS
DEAJNO (Midwest Research Institute, Kansas City, MO, U.S.A.) was made available through the courtesy of Dr. Larry Keefer, the National Cancer Institute (Freder ick, MD, U.S.A.). DETC and N-nitro-L-arginine methyl ester (L-NAME) were purchased from Aldrich Chemicals (Milwaukee, WI, U.S.A.) and Sigma Chemicals (St. Louis, MO, U.S.A.), respectively. All reagents were pre pared in saline solutions. The L-NAME solution was ad justed to neutral pH with NaOH.
Male Sprague-Dawley rats, weighing 20�300 g, were used. Anesthesia was induced with 4% isoflurane. After the tracheal intubation, the anesthesia was maintained with 1% isoflurane170% Nz0/30% Oz, which was deliv ered through a Harvard rodent ventilator (model 638). The tidal volume and the rate of respiration were adjusted to maintain blood gases at physiological levels. A catheter J Cereb Blood Flow Metab, Vol. 14, No.5, 1994 was inserted into the femoral artery for continuous mon itoring of systemic blood pressure and for sampling blood to analyze blood gas by a pHlblood gas analyzer (Chiba Cornig model 168). An additional catheter was inserted into another femoral artery to induce hemorrhagic hy potension. Body temperature was kept at 37-37SC by a heat lamp during experiments. Forebrain ischemia was produced by a combination of bilateral common carotid artery (CCA) occlusion with aneurysmal clips and arterial hypotension (MABP = 50 mm Hg) produced by with drawal of arterial blood (Smith et aI., 1984) . We measured EEG (Windgraf recorder model 40-8474-00 and Bioelec tric signal conditioner model 13-6615-58; Gould, Valley View, OH, U.S.A.) and confirmed that a flat EEG was observed within a few minutes after the onset of ischemia.
During the forebrain ischemia, isoflurane was discon tinued and anesthesia was maintained with an NzOIOz gas mixture. DETC (l0�500 mglkg) was injected intraperito neally or subcutaneously 30 min prior to the onset of ischemia. Fe-citrate (weight ratio, FeS04 • 7HzO/sodium citrate = 1:5; range of FeS04 • 7HzO, 8-120 mg/kg) was injected subcutaneously 30 min prior to the onset of isch emia. When the effect of L-NAME (45 mg/kg) was tested, the L-NAME solution was continuously infused via the femoral vein from 30 min before the ischemia using a Harvard infusion pump (1 mg/kg/min). After 15 min of forebrain ischemia, the rat was killed by decapitation un der anesthesia. The control rats underwent similar pro cedures but without carotid artery occlusion and hy potension. The cerebral cortex was transferred into a 3-ml plastic syringe mounted with a 12-in-Iong infusion tubing and extruded into a 4-mm (i. d.) EPR tube (Wilmad Glass Co, Buena, NJ, U.S.A.). The specimen was imme diately frozen and kept at liquid nitrogen temperature un til its EPR measurement.
EPR spectra were recorded using a Varian E-109 spec trometer with a liquid nitrogen flow system at 110 ± 10K. The conditions for EPR measurements were as follows: 9.22-GHz microwave frequency, 100-kHz modulation fre quency, 0.32-mT modulation, and 0.25-s time constant.
DEA/NO [EtzN-N(ONa)-N = 0], the sodium salt of the diethylamine/nitric oxide complex, was used as an NO generator to calibrate the NO concentrations. DEAINO is stable in alkaline solutions, but a molecule of DEAJNO releases 1.5 NO molecules under neutral or acidic condi tions within a few minutes (Maragos et aI., 1991) . An alkaline DEA/NO stock solution was diluted into an Nzequilibrated, 3 mM phosphate-buffered saline solution (pH 7.4) at room temperature. The concentrations of NO generated in the perfusates were 0, 10, 20, and 50 J..l M. Since the decomposition of DEAJNO is relatively rapid, DEA/NO might be fully decomposed to produce NO rad icals under this condition. Thirty minutes after the admin istration of DETC (400 mg/kg) and FeS04 (20 mg/kg)/Na citrate (100 mg/kg), the rat was perfused under anesthesia with the neutral DEA/NO solution via the ascending aorta at a pressure of 100 mm Hg for 15 min. Then the brain was removed quickly and the EPR sample was prepared in the same manner as mentioned previously. All solutions used in this experiment were degassed under. vacuum and equilibrated with Nz by bubbling. All containers were also filled with Nz. The signal heights of NO-Fe-DETC complex in these DEA/NO experiments (see Fig. 5 ) were plotted against NO concentrations in the perfusate. The concentrations of the trapped NO were estimated from this calibration curve.
RESULTS
The parameters including blood gas (pH, P a02, P aC02) and body temperature were within physio logical ranges. MABP was lowered when a high dose of DETe was used (see following); otherwise, it remained above 80 mm Hg during the experi ments.
During the EPR measurement, two types of sig nals were detected: a quartet spectrum from eu DETe, which is identical to those documented pre viously (Voevodskaya and Vanin, 1992) , and a trip let signal derived from NO-Fe-DETe. Figure la shows a spectrum in which only DETe was admin istered to a control animal. The spectrum shows a quartet hypertine structure of eu-DETe as indi cated by arrows. When the brain was exposed to global ischemia in the absence of Fe-citrate, the spectra did not change their characteristic shape (data not shown). When Fe-citrate was adminis tered simultaneously with DETe, a small peak and a trough appeared at g = 2.047 and at g = 2.025, respectively ( Fig. Ib) . By administration of L-NAME, these signals disappeared (Fig. lc) . Therefore, the small peak and trough are related to the production of NO from L-arginine. When the rat was exposed to severe hypotension (MABP of <30 mm Hg, 5 min), the typical NO-Fe-DETe signal, which was a clear triplet centered at g = 2.039 with a hypertine coupling constant aN of 13 G, was ob served (Fig. Id) .
We examined the microwave power dependence of the NO-Fe-DETe and eu-DETe signals (shown by "N" and "e," respectively, in Fig. Id) . We found that an optimal signal-to-noise ratio of the NO-Fe-DETe signals was obtained at the micro wave power of 20 mW and sample temperature of 1100K ( Fig. 2a, middle) . The power saturation pro files of NO-Fe-DETe and eu-DETe are shown in Fig. 2b . At �2 mW, both signals started to deviate from the non saturated line, which has a slope of V2. At 20 mW, the eu-DETe signal was already quite saturated, but the level of saturation of the NO-Fe DETe signal was acceptable for the measurement.
Since it was noticed that DETe has a hypoten sive effect, we examined the effects of the route of administration and the dosage of DETe on MABP of the rat. Originally, Kubrina et al. (1992) used 500 mg/kg of DETe for NO trapping in mice. However, in our experiment, 500 mg/kg of DETe evoked sig nificant hypotension «70 mm Hg, regardless of the route of its administration), which is below the lower limit of autoregulation of the cerebral circu lation. The values (means ± SD) of MABP at 30 min after the administration of DETe were as follows: FeS0 4 (40 mg/kg)/Na citrate (200 mg/kg); a small peak (g = 2.047) and a trough (g = 2.025) are portions of NO-Fe-OETC. c: OETC + Fe + L-NAME (45 mg/kg); note the disappearance of the NO-Fe-OETC found in the signal (b). d: OETC + Fe; severe hypotension (MABP < 30 mm Hg, 5 min). EPR condi tions: 20-mW microwave power, 1.0 x 10 4 gain, 0.32-mT modulation, 9.22-GHz microwave frequency, and 100-kHz modulation frequency. Temperature was 110 ± 10K. For ab breviations see the text.
DETe 500 mg/kg i.p., 63.5 ± 12.9 mm Hg (p = to); DETe 500 mg/kg s.c., 68.5 ± 5.4 mm Hg (n = 4); DETe 400 mg/kg s.c., 81.3 ± 7.8 mm Hg (n = 10). When DETe was administered subcutaneously, the value of MABP with 400 mg/kg of DETe was sig nificantly higher than that with 500 mg/kg of DETe (p < 0.01, Student's t-test). It was kept above 80 mmHg, which probably is in an acceptable range. Figure 3 shows the relationship between the con- mg/kg)/Na-citrate (100 mg/kg) subcutaneously for further studies. The signal of Cu-DETC reached a maximum at 30 min after the administration of DETC and then declined (data not shown). Figure 4b is an EPR spectrum for a moderately hypotensive rat (MABP = 50 mm Hg, 15 min) with out CCA occlusion. It shows a slightly potentiated production of NO indicated by a higher peak at g = 2.047 and a deeper trough at g = 2.025 in compar ison with the control spectrum (Fig. 4a ). When the rat was exposed to forebrain ischemia for 15 min, the production of NO was demonstrated by a dis tinct triplet signal of the NO-Fe-DETC (Fig. 4c ) with a much higher peak at g = 2.047 and a much deeper trough at g = 2.025. Figure 5 shows the calibration curve for the esti mation of the trapped NO concentration. The EPR signals were obtained from the rats perfused with DEA/NO solutions (pH 7.4). The size of the NO Fe-DETC signal was estimated by the height indi cated by "N" in the inset. Along with the increase of the NO concentration in the perfusate, the NO Fe-DETC signal exhibited proportional growth, while the size of the Cu-DETC signal remained con stant. The signal height "N" was well correlated with the NO concentration in the perfusate (corre lation coefficient r = 0.998, p < 0.01). With use of this calibration method, the amount of trapped NO during forebrain ischemia was estimated to be 10.9 ± 3. 4 flM (mean ± SD, n = 4), while the value for the control rat was 1. 6 ± 0.5 flM (n = 5). The difference between these groups was statistically significant (ANOV A-Fischer's PLSD, p < 0.01). Hg, 15 min); and c: and forebrain ischemic rat (15 min). DETC (400 mg/kg) and FeS0 4 (20 mg/kg)/Na citrate (100 mg/kg) were administered 30 min before the onset of hemorrhagic hypotension or forebrain ischemia. The EPR conditions were the same as those in Fig. 1 .
The value for the moderate hypotension (MABP = 50 mm Hg) was estimated to be 5.8 ± 0.8 fLM, which is significantly greater than that of the control (n = 3, p < 0.05).
DISCUSSION
The EPR signal of NO-metal complexes is highly specific to the electronic state of transition metals and the structure of ligands. Fe-DETC and hemo globin-CO (HbCO) are currently available as NO trapping agents (Kosaka et aI. , 1992; Kubrina et ai. , 1992; Voevodskaya and Vanin, 1992) . Since HbCO is not suitable for systemic administration, we have chosen Fe-DETC as a reagent to trap NO in the brain. The signal height of the NO-Fe-DETC com plex was found to increase with an increase of the concentration of administered DETC up to at least 500 mg/kg (data not shown). However, higher doses of DETC, over 400 mg/kg, were found to decrease blood pressure below the lower limit of autoregula tion. Without administration of exogenous Fe, the rat brain does not generate NO-Fe-DETC, which is different from the mouse brain (Kubrina et aI., 1992) . However, an excessive amount of Fe was found to provoke NO formation by itself, presum ably through membrane damage and consequent Ca 2 + influx (Kubrina et aI., 1993) . Considering these characteristics of the NO-trapping reagents, we found that the subcutaneous administrations of 400 mg/kg DETC and 20 mg/kg FeS04 are appro priate for our studies.
The Fe-DETC complex is not water soluble (the solubility is < 10 -5 M) and predominantly localized in cell membranes (Vedernikov et aI., 1992) . DETC alone can penetrate the blood-brain barrier, but Fe ions may not (Crowe and Morgan, 1992) . Therefore, it seems unlikely that the Fe-DETC complex is formed in the brain parenchyma. Endothelial cells may be the site of NO trapping with Fe-DETC. Pos sible sources of NO in the brain include neurons (Bredt et aI., 1992) , endothelial cells (Palmer et aI., 1988) , perivascular parasympathetic nerve fibers (N ozaki et aI., 1993), vascular smooth muscle cells (Bernhardt et aI., 1991) , and glial cells (Galea et aI., 1992; Simmons and Murphy, 1992) . In the ischemic brain, the exact mechanism of NOS activation is yet to be determined. Since the NOS activity is �20
.� Example of EPR spectra. The size of the NO signal indicated as "N" was well correlated with the concentration of NO in the perfusate (correlation coefficient r = 0.998, P < 0.01). An asterisk indicates the size of the NO signal of the forebrain ischemic rat shown in Fig. 4c . For abbreviations see the text.
times higher in neurons than in endothelial cells (Schmidt et aI., 1993) , the NO trapped in our study might be derived not only from blood vessels, but also from parenchymal neurons. Glial cells such as astrocytes and microglia can produce NO under limited conditions (Galea et aI., 1992; Simmons and Murphy, 1992) . In the present study, it is less pos sible that glial cells contribute to the formation of NO, because the expression of an inducible form of NOS requires a longer period of reaction (Galea et aI., 1992; Simmons and Murphy, 1992) . Blood itself did not produce NO-Fe-DETC signals under the conditions employed here (data not shown).
To calibrate the concentration of trapped NO, it is desirable to produce a known amount of NO un der similar conditions. For this purpose, we applied transcardiac perfusion of a DEA/NO solution, be cause 1 mole of DEAlNO is known to generate 1.5 moles of NO at physiological pH. In performing the calibration, we made the following assumptions: (a) The Fe-DETC complex is absorbed into the surface membrane of the endothelial cells. (b) Under nor mal or ischemic conditions, NO radicals produced in the brain are trapped by this absorbed complex. (c) In the calibration experiments with DEA/NO, NO in the DEA/NO perfusate is also similarly trapped by this absorbed complex.
It is known that Hb quenches NO radicals. How ever, we observed that blood can be largely washed out during the first few minutes of perfusion. We believe that the effect of Hb in our calibration is not significant. As shown in Fig. 5 , there was a small NO signal even when the brain was perfused with 3 mM sodium phosphate buffer not containing DEAl NO. It may be derived from ischemia caused by phosphate buffer perfusion. Therefore, this signal was considered to be the baseline NO production and was subtracted in forming the calibration curve (see Fig. 5 ).
A small peak and trough that appeared in the non ischemic control rats were portions of the NO sig nal. The size of these signals did not change with a change of the amounts of reagents or with a change in the route of administration. Therefore, the value obtained from the control rats seems to represent the basal level of trapped NO. As shown in Fig. 5 , the NO-Fe-DETC signal increased up to 50 jJ-M lin early with an increase of NO generated by DEAl NO. This suggests that the concentration of ab sorbed Fe-DETC was sufficient to trap the NO up to 50 jJ-M and that the signal height of the NO-Fe DETC is proportional to the NO concentration within this range. With this calibration procedure, the amount of trapped NO in forebrain ischemia was estimated to be 10.9 ± 3.4 jJ-M. The values J Cereb Blood Flow Metab, Vol. 14, No.5, 1994 were 5.8 ± 0.8 and 1. 6 ± 0.5 jJ-M for the hypoten sive and control rats, respectively. These values are higher than those reported by Vanin et aI., who measured the amount of NO-Fe-DETC complex in -v-irradiated mice (2 jJ-M) using Fe 2 + (S 2 03 2 -MNOh complex as a standard paramagnetic sample (V 0evodskaya and . Recently, Malinski et ai. (1993) measured the production of NO in focal cerebral ischemia using a porphyrinic microsensor and reported a value of �2 jJ-M. The electrode method has the advantage that it allows continuous recording. Their value of 2 jJ-M represents the av erage local NO concentration near the tip of the electrode. The value estimated by the NO-trapping technique is the concentration of NO in a solution that is in equilibrium with the "trapped" NO at the surface of the blood vessel. Therefore, the value estimated by our method may be different from the value obtained by the on-line microelectrode method.
The NO-trapping method has an inherent disad vantage in that the NO-trapping agent itself reduces the concentration of the radicals produced, and thus it may have an influence on the outcome of pathol ogy. In the present study, the trapping of NO and/or the trapping of Cu in Cu-protein(s) may affect cir culatory conditions in both control and ischemic brains. However, the effect of NO trapping is ap parently different from that of NOS inhibitors (Prado et aI., 1992) , because Fe-DETC induces hy potension, while NOS inhibitors induce hyperten sion. Thus, NO trapping with Fe-DETC does not seem to abolish the vasodilating activity of NO completely. Instead, vasorelaxation by an uniden tified complex containing NO and DETC may occur (Vedernikov et aI. , 1992) . This remains to be deter mined.
In addition, the concentrations of Cu and Fe in the blood vessels may be increased in the ischemic brain (Chevion et aI., 1993) , thereby enhancing the detection of NO. However, this effect seems to be small, since brain tissue does not have sufficient free Fe to form the NO-Fe-DETC complex even in ischemia (Tominaga et aI. , 1993) .
DETC is also known to inhibit the activities of Cu-containing proteins such as Cu/Zn superoxide dismutase. Since superoxide anions can quench NO by forming nitrites, nitrates, and peroxynitrites (Rubanyi and Vanhoutte, 1986; Beckman, 1991) , the inhibition of Cu/Zn superoxide dismutase re sults in a decrease of NO concentration. Thus, our values of NO concentrations would again underes timate actual NO production.
The present study provides evidence that fore brain ischemia significantly potentiates NO forma-tion in the cerebral cortex. This potentiation may be a physiological response of endothelial cells for maintaining blood flow in the face of severe isch emia. NO has many biological effects directly asso ciated with the evolution of ischemic injury. Va sorelaxation during the very early phase of ischemia (Morikawa et aI., 1992) , the inhibition of platelet and leukocyte adhesion (Radomski et aI., 1987; Kubes et aI., 1991) , and the blockade of NMDA receptors (Lei et aI., 1992; Manzoni et aI., 1992) may protect the brain from ischemic injury. The cytotoxicity of NO through the formation of perox ynitrites (Beckman, 1991) , the mediation of gluta mate neurotoxicity (Dawson et aI., 1991) , and the inhibition of several enzymes containing a nonheme iron-sulfur complex (Salerno and Ohnishi, 1976; Dawson et aI. , 1992 ) may exacerbate injury. The net effect of these mechanisms could result in variable outcomes in different ischemia models, depending on the severity and timing of the ischemia (Uemura et aI., 1990; Nowicki et aI., 1991; Buisson et aI., 1992; Dawson et aI., 1992; Morikawa et aI., 1992; Nagafuji et aI., 1992; Sancesario et aI., 1992; Trifi letti, 1992; Yamamoto et aI., 1992) .
In conclusion, we demonstrated the usefulness of an EPR NO-trapping technique for the study of NO production in the ischemic rat brain. This method may contribute to the study of the roles of NO in various brain pathologies.
